Navigation Links
Repligen in Medical News

Repligen Licenses Patent Rights for Treatment of Bipolar Disorder

...WALTHAM, Mass., March 31 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...rogram of any private, U.S. psychiatric hospital. repligen is developing RG2417, an oral formulation of uridi... Herlihy, President and Chief Executive Officer of repligen Corporation. "Treatment of the symptoms of bipola...

Repligen Announces ISO 9001:2000 Certification

... WALTHAM, Mass., Feb. 12 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ), a global leader in ...lated services underlying its Protein A business. repligen has supplied Protein A products to the biopharmace...ent and Chief Executive Officer of Repligen. repligen is the world's leading supplier of recombinant Pro...

Repligen Reports Second Quarter Fiscal Year 2009 Financial Results

... WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported result... Herlihy, President and Chief Executive Officer of repligen Corporation. "As of September 30th, we had $65 mil...cologic, toxicologic and pharmacodynamic profiles. repligen announced receipt of a $1 million research grant f...

Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder

... WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...d relapse remain common clinical problems. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST

... WALTHAM, Mass., Oct. 30 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... be accessed at http://www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Compound Reverses Huntington's Symptoms in Mice

...published this week in the early edition of the Proceedings of the National Academy of Sciences . The study received funding from Massachusetts-based repligen Corp., which holds several patent applications related to HDAC (histone deacetylase) inhibitors, a class of agents that include HDACi 4b. Other HDA...

Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors

... WALTHAM, Mass., July 1 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "Fred's expertise and relationships w...es and is an inventor on numerous patents. About repligen Corporation ...

Repligen Announces Share Repurchase Program

... WALTHAM, Mass., June 18 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced that ...,000 shares of its common stock. Under the program repligen may repurchase shares from time to time at prevail... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our strong financial position will a...

Repligen Announces Conference Call to Update Orencia(R) Lawsuit

... be accessed at http://www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...lings with the Securities and Exchange Commission. repligen assumes no obligation to update any forward-lookin...

Repligen Elects Earl Henry, M.D. to the Board of Directors

... WALTHAM, Mass., Dec. 13 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "Earl's strategic guidance and relati...rovider of clinical outsourcing solutions. About repligen Corporation ...
Repligen in Medical Technology

Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications

...Schimmel has also been the co-founder or founding director of numerous successful biotechnology companies, including Sirtris Pharmaceuticals, Alnylam, repligen Corporation, Alkermes, Inc., Momenta Pharmaceuticals and Cubist Pharmaceuticals, which were taken public on the NASDAQ and are well established as com...

Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer

...ing drugs to treat inherited and acquired energy impairment diseases. Dr. Rioux' three-decade career includes industry experience at companies such as repligen Corp., Arrow International, Variagenics, Inc., Biogen and GRP (Groupement de Recherche en Pharmacologie). He previously was a researcher in Clinical R...

Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder

... WALTHAM, Mass., June 12 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced that ...ill be the Principal Investigator of this study. repligen previously reported positive initial results from ...d over $200 million in funding since 1989. About repligen Corporation ...

Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging

...WALTHAM, Mass., April 16 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "We expect to complete patient enroll...s year and, if successful, file an NDA in 2009." repligen is currently conducting a Phase 3 clinical trial t...

Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging

...WALTHAM, Mass., March 26 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "There are approximately 150,000 panc...t could benefit from enhancement with secretin." repligen previously conducted a multi-center, baseline-cont...

Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder

... WALTHAM, Mass., Nov. 8 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced posit... Herlihy, President and Chief Executive Officer of repligen Corporation. "The results of this study support fu...ed over $200 million in funding since 1989. About repligen Corporation ...

Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas

... of Orphan Products Development of the FDA granted repligen orphan drug designation for RG1068, synthetic huma...of the pancreas. Orphan drug designation qualifies repligen for seven years of exclusive marketing rights in t...or RG1068 for MRI imaging of the pancreas. About repligen Corporation ...
Repligen in Biological Technology

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

... WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our financial resources will allow ...ge in Bipolar Disorder scale (CGI-BP-C). In March, repligen exclusively licensed worldwide rights to a patent ...

Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results

... WALTHAM, Mass., July 30 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...e accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results

... WALTHAM, Mass., June 11 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Over the next twelve months, we wil...DRS (p=0.01) and the CGI-BP-C (p=0.04). In March, repligen exclusively licensed worldwide rights to a patent ...

Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results

... WALTHAM, Mass., June 4 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that... be accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the Cowen and Company 29th Annual Healthcare Conference Monday, March 16th, 2:25 p.m. EDT

... WALTHAM, Mass., March 9 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...or 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Reports Third Quarter Fiscal Year 2009 Financial Results

... WALTHAM, Mass., Feb. 5 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our financial resources will allow ...s. Stock Repurchase Program In June 2008, repligen announced that its Board of Directors authorized t...

Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST

... WALTHAM, Mass., Feb. 2 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...or 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results

... WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...ay be accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST

... WALTHAM, Mass., Nov. 3 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...ed for 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT

...WALTHAM, Mass., Sept. 17 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...ed for 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...
Repligen in Biological Dictionary

Affymetrix

...t news headlines at MainStreet.com Research AFFYMETRIX INC historical prices, historical volume, splits and dividends. ... Orexigen Therapeutics, repligen and Affymetrix lead small-cap volume in ... Affymetrix to Host Conference Call on July 22, 2009 to Announce Second Quarter 2009 Results ... Af...
Other Tags
(Date:9/19/2014)... published today in the online journal PLoS Outbreaks ... West Africa by the end of the month if ... State University and Harvard University researchers also discovered through ... significantly increased in August in Liberia and Guinea, around ... place, indicating that the mass quarantine efforts may have ...
(Date:9/19/2014)... NY (PRWEB) September 20, 2014 As summer ... Krishnan DMD in Queens, NY now reminds area patients about ... than 80% of our population affected by gum disease, there ... longer.” , For over 20 years Dr. Krishnan has treated ... Hills office location. “Most patients that come in due to ...
(Date:9/19/2014)... led by Medical College of Wisconsin (MCW) scientists has identified ... in rats, mice and in humans. The findings are published ... , Leah Solberg Woods, Ph.D., associate professor of pediatrics ... Wisconsin Research Institute, led the study and is the corresponding ... identified a gene called Tpcn2 in which a variant was ...
(Date:9/19/2014)... 19, 2014 Capital Region Periodontics ... is excited to announce the latest addition to ... gingivitis and those needing dental implants. Often referred ... treatment removes the fear factor normally associated with ... discomfort and bleeding make, this procedure a very ...
(Date:9/19/2014)... researchers say a simple test that combines thinking ... for developing Alzheimer,s disease in a person, even ... dementia., Faculty of Health Professor Lauren Sergio and ... asked the participants to complete four increasingly demanding ... computers. The test aimed at detecting the tendency ...
Breaking Medicine News(10 mins):Health News:Research predicts possible 6,800 new Ebola cases this month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3Health News:Albany, NY Periodontist Reed Ference, DMD, Calms Fears of Patients with Gum Disease by Offering LANAP®, An Advanced, Less Invasive Treatment Solution 2Health News:Albany, NY Periodontist Reed Ference, DMD, Calms Fears of Patients with Gum Disease by Offering LANAP®, An Advanced, Less Invasive Treatment Solution 3Health News:Simple test can help detect Alzheimer's before dementia signs show: York U study 2
(Date:9/18/2014)... is probably the ultimate form of camouflage: you don,t ... this strategy is not as uncommon as you might ... County, USA, explains that the larval life stages of ... part of the anatomy that most creatures cannot make ... have to shield each individual eye unit with an ...
(Date:9/17/2014)... to reproductive technologies, the justice and well-being of ... to identify key issues, articulate their values and ... most defensible ways forward. But what are the ... The Hastings Center and the Presidential Commission for ... to publish a series of essays to highlight ...
(Date:9/17/2014)... his doctoral student have designed a device based on ... fog and dew., The device could provide water in ... globe., Cheng Luo, professor in the Mechanical & Aerospace ... same College of Engineering department, published "Bioinspired Plate-Based Fog ... Chemical Society) Applied Materials & Interfaces ...
Breaking Biology News(10 mins):Transparent larvae hide opaque eyes behind reflections 2Why bioethics literacy matters 2Why bioethics literacy matters 3Shorebird's beak inspires UT Arlington research on water collection 2
Other Contents